Disclosures for "Treatment of Hypertrophic Pachymeningitis: A Systematic Review"
-
Mr. Araruna Dias has nothing to disclose.
-
An immediate family member of Fernando Melo Neto has received personal compensation in the range of $0-$499 for serving as a Consultant for Origen Health. An immediate family member of Fernando Melo Neto has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. An immediate family member of Fernando Melo Neto has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. An immediate family member of Fernando Melo Neto has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Horizon. An immediate family member of Fernando Melo Neto has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Merck. An immediate family member of Fernando Melo Neto has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Novartis. An immediate family member of Fernando Melo Neto has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Horizon. An immediate family member of Fernando Melo Neto has received research support from Biogen.
-
Miss Viana has nothing to disclose.
-
Mrs. Lisboa has nothing to disclose.
-
-
Dr. De Siqueira Lima has stock in Moderna. Dr. De Siqueira Lima has stock in Johnson & Johnson. Dr. De Siqueira Lima has stock in Pfizer.
-
-
Dr. Etelvina has received personal compensation in the range of $0-$499 for serving as a Consultant for Origen Health. Dr. Etelvina has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Etelvina has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Etelvina has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Horizon. Dr. Etelvina has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Merck. Dr. Etelvina has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Novartis. Dr. Etelvina has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Horizon. Dr. Etelvina has received research support from Biogen.